Inventiva’s lanifibranor has been tipped to become a blockbuster in the fatty liver disease non-alcoholic steatohepatitis (NASH) after it became the first drug to hit two regulatory goals in a trial.

Intercept Pharmaceuticals has accused the FDA of moving the goalposts during its review of a potential blockbuster drug for the fatty liver disease known as NASH following a rejection. Intercept’s CEO ...

Chhattisgarhi asmita (pride), a key issue in the assembly polls of 2023, has made a comeback on the state's political stage. The trigger is the open war of words between members of the Sindhi and ...

Kim Nash is an editor who manages a team of reporters covering cybersecurity and data-privacy issues for The Wall Street Journal's Pro unit in New York. Her team’s stories explore how companies ...

Non-alcoholic steatohepatitis (NASH) is a condition characterized by accumulation of fat, inflammation and injury in liver cells in people who consume little or no alcohol. It is the progressive form ...

A row that erupted over a bust of state icon Chhattisgarh Mahtari and escalated has spotlighted the self-styled 'son of soil' Amit Baghel Share Chhattisgarhi asmita (pride), a key issue in the ...

If you ever want to know what brunch with a Chief Minister looks like, then you must tune into our latest Sunday Brunch episode. Our Editor-in-Chief Kamiya Jani, met Chhattisgarh Chief Minister Vishnu ...

Enjoy a candlelight concert in Kew’s historic glasshouse. The Nash Sessions are a unique opportunity to enjoy sensational music – from jazz to classical – by candlelight in the stunning surroundings ...